Literature DB >> 31079065

Gyrification abnormalities in presymptomatic c9orf72 expansion carriers.

Eduardo Caverzasi1, Giovanni Battistella2, Maria Luisa Gorno-Tempini3, Suzee E Lee2, Stephanie A Chu3, Howie Rosen3, Theodore P Zanto2, Anna Karydas2, Wendy Shwe3, Giovanni Coppola4, Daniel H Geschwind5, Rosa Rademakers6, Bruce L Miller3,7.   

Abstract

OBJECTIVE: To investigate in-vivo cortical gyrification patterns measured by the local gyrification index (lGI) in presymptomatic c9orf72 expansion carriers compared with healthy controls, and investigate relationships between lGI and cortical thickness, an established morphometric measure of neurodegeneration.
METHODS: We assessed cortical gyrification and thickness patterns in a cohort of 15 presymptomatic c9orf72 expansion carriers (age 43.7 ± 10.2 years, 9 females) compared with 67 (age 42.4 ± 12.4 years, 36 females) age and sex matched healthy controls using the dedicated Freesurfer pipeline.
RESULTS: Compared with controls, presymptomatic carriers showed significantly lower lGI in left frontal and right parieto-occipital regions. Interestingly, those areas with abnormal gyrification in presymptomatic carriers showed no concomitant cortical thickness abnormality. Overall, for both presymptomatic carriers and healthy controls, gyrification and cortical thickness measures were not correlated, suggesting that gyrification captures a feature distinct from cortical thickness.
CONCLUSIONS: Presymptomatic c9orf72 expansion carriers show regions of abnormally low gyrification as early as their 30s, decades before expected symptom onset. Cortical gyrification represents a novel grey matter metric distinctive from grey matter thickness or volume and detects differences in presymptomatic carriers at an early age. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31079065      PMCID: PMC6820159          DOI: 10.1136/jnnp-2018-320265

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


Introduction

A hexanucleotide expansion in c9orf72 (C9) is the most common genetic cause of familial and sporadic frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).1 2 Previous studies show that presymptomatic c9orf72 expansion carriers (preSxC9) have deficits in grey matter volume, white matter integrity3–5 and disruption of functional connectivity networks as soon as their early 30s, decades before expected symptom onset.4 These abnormalities may represent incipient neurodegeneration, abnormal brain development or both. Whether such deficits represent neurodevelopmental differences vs early atrophy, however, remains an open question. Brain development is an intricate and complex process that begins during gestation and continues through early adulthood. Cortical folding, or gyrification, represents a dynamic phenomenon allowing for abundant expansion of the cortical surface.6 7 During the third trimester of fetal life, gyrification proliferates rapidly, and the brain grows from a relatively smooth surface towards a gyrification pattern resembling the adult brain.8 9 Gyrification declines exponentially throughout childhood and adolescence, and then declines more linearly during adulthood, and these declines in gyrification arise in parallel with age-related volume loss.7 10 With novel morphometric MRI techniques, three-dimensional cortical folding patterns can be evaluated in-vivo by computing the local gyrification index (lGI), defined as the ratio between the cortex buried within sulcal folds and the area of the cortical surface.11 In children with neurodevelopmental disorders such as dyslexia and autism, specific brain regions show a higher degree of cortical folding compared with typically developing children.12–15 In dyslexia, this abnormally higher gyrification may be due to the absence of the age-related gyrification decline seen in typically developing children. Studies in adults have revealed abnormal gyrification trajectories in patients with major psychiatric disorders (ie, depression, bipolar disorder and schizophrenia)10 and neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases.16 17 In contrast to the pattern seen in neurodevelopmental disorders, patients with Alzheimer’s disease show abnormally low gyrification associated with sulcal widening, reduced cortical thickness and cognitive decline.16 To date, no study has applied this novel metric to assess gyrification in presymptomatic carriers of any neurodegenerative disease-causing mutations. We hypothesised that presymptomatic c9orf72 expansion carriers would have abnormally increased cortical gyrification as seen in dyslexia and autism, reflecting neurodevelopmental differences. In the present study, we assessed cortical gyrification and cortical thickness in 15 preSxC9 compared with age and sex matched healthy controls (HC).

Methods

Subjects

We compared 15 preSxC9 (age 43.7±10.2 years, 9 females) to 67 (age 42.4±12.4 years, 36 females) age and sex matched HC. Demographic characteristics and neuropsychological test scores did not statistically differ between groups and are reported in a previous study.4 In genetic FTD, mean familial age of onset correlates with age of symptom onset in symptomatic carriers.5 Thus, the estimated time to symptom onset for a presymptomatic carrier was calculated by determining the difference between the carrier’s age and the mean familial age of onset. The estimated time to symptom onset of the presymptomatic carriers in the present study was 8.2±11.0 years. The University of California, San Francisco Committee on Human Research approved the study. Participants provided informed consent prior to participation.

Image acquisition

All subjects underwent MRI scanning on a Siemens Tim Trio 3T scanner. Structural volumetric T1-weighted imaging was acquired with the following parameters: TR/TE 2300/2.98 ms; flip angle 9; 160 sagittal slices; voxel size=1 mm3; matrix size 240 x 256.4

Freesurfer-based cortical thickness and lGI analyses

The preprocessing of T1-weighted images was performed using FreeSurfer V.5.3 (http://surfer.nmr.mgh.harvard.edu/) in accordance with a standard autoreconstruction algorithm. The pipeline included intensity normalisation, removal of non-brain tissue using a watershed algorithm technique, generation of the surface mesh representations using a surface deformation algorithm, tessellation of the grey matter boundary, automated topology correction and Talairach-Tournoux transformation.18–20 The accuracy of the segmentation results was validated by a neuroradiologist (EC). Cortical thickness measures were obtained based on the shortest distance between the grey matter/ white matter and grey matter/ cerebrospinal fluid boundaries at each vertex of the tessellated surface. Gyrification of the entire cortex was also assessed using FreeSurfer. lGI was computed using the method described by Schaer and colleagues.11 21 Cortical thickness and lGI images were normalised to the fsaverage space (MNI305 template) and smoothed with a full-width at half maximum Gaussian kernel of 15 mm for cortical thickness and 5 mm for lGI (figure 1).7
Figure 1

Example of an individual subject lGI map. (A) Lateral view of the native space cortical surface of one healthy control subject (male, 57 years old) and (B) lateral view of the lGI map overlaid on the FreeSurfer fsaverag e template. Regions with a higher lGI indicate a greater degree of gyrification. The ‘heat’ colour bar represents lGI values, ranging from 0 to 5. lGI, local gyrification index.

Example of an individual subject lGI map. (A) Lateral view of the native space cortical surface of one healthy control subject (male, 57 years old) and (B) lateral view of the lGI map overlaid on the FreeSurfer fsaverag e template. Regions with a higher lGI indicate a greater degree of gyrification. The ‘heat’ colour bar represents lGI values, ranging from 0 to 5. lGI, local gyrification index.

Statistical analysis with AFNI

We examined group differences (preSxC9 vs HC) in cortical thickness and lGI using independent two-sample t-tests (AFNI 3dttest++, www.afni.nimh.nih.gov) at two thresholds: p<0.001 uncorrected and p<0.05 corrected for family-wise error (FWE). We performed the FWE multiple comparison correction using the ‘slow_surf_clustsim.py’ and ‘quick.alpha.vals.py’ tools in the AFNI software package. We chose to report results at p<0.001 uncorrected, consistent with the previous study.4 These t-tests perform a vertex-by-vertex regression over the whole cortical surface to estimate the mean difference of the input data between the two groups. Participants’ age, gender and cortical thickness (for the lGI comparison) were included as covariates of no interest.22 To explore potential differences between groups with respect to age, we examined group as an interaction term for the relationship between lGI and age. We also computed the effect size measured by Cohen’s d (d) for each cluster found to have significantly lower lGI in the presymptomatic carriers; this was obtained by dividing the difference between mean values by the common SD of the two groups.23 With the effect size, we performed a power calculation for a two-tailed analysis using an alpha value of 0.05.

Relationship between cortical thickness and lGI

We performed a Pearson correlation analysis across the grey matter in all subjects to assess for potential associations between cortical thickness and lGI. We also performed a least squares regression (LSR) analysis to quantify the variance attributable to group, age or cortical thickness within the map of regions in which preSxC9 showed significantly abnormal lGI compared with HC. We used the JMP PRO 14 statistical programme to perform this analysis.

Results

PreSxC9 show regions of lower gyrification compared to healthy controls

PreSxC9 showed four regions of lower lGI compared with controls (pFWE <0.05) in the left subgenual anterior cingulate cortex, left precentral gyrus, right inferior parietal lobule and right superior occipital gyrus (figure 2 and table 1). The effect size measured by Cohen’s d was large (d=1.0) in each significant cluster with a power of 93.3%. A trend (p<0.001 uncorrected) towards lower lGI emerged in the left orbitofrontal, insular and occipital cortices and right parietal cortex (figure 2 and table 1). There were no regions for which preSxC9 had a significantly greater lGI compared with controls.
Figure 2

PreSxC9 show regions with low local gyrification index. Regions with significantly lower local gyrification index emerged in preSxC9 compared with controls (p<0.001 uncorrected, cyan). Regions in left precentral gyrus, left subgenual anterior cingulate, right superior occipital cortex and right inferior parietal lobule remained significant at pFWE <0.05 (dark blue). FWE, family-wise error.

Table 1

Regions showing lower local gyrification in preSxC9

Local gyrification index
ClusterAreaT valueMNI xMNI yMNI z
Left-sided Subgenual anterior cingulate (L) * 218.063.60−3.7929.66−9.49
Precentral (F) * 174.373.69−28.21−24.6162.59
Middle occipital (O)79.593.65−27.88−95.3411.38
Sup occipital (O)77.583.55−13.86−95.8919.84
Orbito frontal (F)57.513.52−23.1411.71−24.32
Ant insula (L)56.013.58−29.8722.84−7.97
Central sulcus (F-P)40.343.49−42.39−15.1233.48
Orbito frontal (F)27.443.55−41.3527.92−16.78
Right-sided Sup occipital (O) * 273.913.7632.38−73.1230.84
Inferior parietal (P) * 142.503.5434.03−40.3041.84
Sup occipital (O)109.243.5525.83−83.9425.06
Supramarginal (P)73.043.6252.27−33.9628.92
Angular (P)67.803.5950.63−57.9439.87
Postcentral (P)55.013.5254.09−19.8145.29
Supramarginal (P)51.113.5554.30−44.7043.17
Sup temporal (T)28.933.4551.19−54.9131.49

The table lists all clusters showing regions of reduced local gyrification index in preSxC9 (p<0.001 uncorrected). Regions in bold font and marked with ‘*’ remained significant after family-wise error correction. We also indicate the brain region to which each cluster belongs: frontal (F), temporal (T), parietal (P), occipital (O) or limbic (L). Clusters’ coordinates are listed in MNI305 space (fsaverage brain of FreeSurfer).

PreSxC9 show regions with low local gyrification index. Regions with significantly lower local gyrification index emerged in preSxC9 compared with controls (p<0.001 uncorrected, cyan). Regions in left precentral gyrus, left subgenual anterior cingulate, right superior occipital cortex and right inferior parietal lobule remained significant at pFWE <0.05 (dark blue). FWE, family-wise error. Regions showing lower local gyrification in preSxC9 The table lists all clusters showing regions of reduced local gyrification index in preSxC9 (p<0.001 uncorrected). Regions in bold font and marked with ‘*’ remained significant after family-wise error correction. We also indicate the brain region to which each cluster belongs: frontal (F), temporal (T), parietal (P), occipital (O) or limbic (L). Clusters’ coordinates are listed in MNI305 space (fsaverage brain of FreeSurfer). We next explored whether carriers and controls might have different cross-sectional relationships between gyrification and increasing age. Across the entire cortical surface, there were no statistically significant regions for which the slope of lGI vs age differed between carriers and controls at either threshold. Within those regions showing lower lGI for preSxC9, both groups showed lGI declines with age, and the slopes of these lGI declines with age did not significantly differ between groups (figure 3).
Figure 3

Relationships with age for regions showing low lGI. We extracted the mean lGI within each of the four regions showing low lGI in preSxC9 compared with HC (at pFWE <0.05). These clusters appeared within left precentral gyrus, left subgenual anterior cingulate, right superior occipital gyrus and right inferior parietal lobule. HC (dark grey), preSxC9 (red) fit lines are shown for visualisation purposes only. Age axis labels are removed to protect participant anonymity. FWE, family-wise error; HC, healthy controls; lGI, local gyrification index.

Relationships with age for regions showing low lGI. We extracted the mean lGI within each of the four regions showing low lGI in preSxC9 compared with HC (at pFWE <0.05). These clusters appeared within left precentral gyrus, left subgenual anterior cingulate, right superior occipital gyrus and right inferior parietal lobule. HC (dark grey), preSxC9 (red) fit lines are shown for visualisation purposes only. Age axis labels are removed to protect participant anonymity. FWE, family-wise error; HC, healthy controls; lGI, local gyrification index. Compared with controls, preSxC9 did not show any differences in cortical thickness at pFWE <0.05. Regions of lower cortical thickness in preSxC9 emerged at p<0.001 uncorrected in frontal, insular, cingulate and occipital cortex bilaterally (online supplementary data). There were no regions for which preSxC9 had a significantly greater cortical thickness compared with controls at p<0.001 uncorrected.

Gyrification and cortical thickness are uncorrelated

To probe whether lGI represents a metric independent from cortical thickness, we correlated cortical thickness and lGI for the entire grey matter across all subjects. There was no significant correlation between cortical thickness and lGI at pFWE <0.05. We next correlated lGI and thickness within each subject subgroup, and no correlations emerged at either threshold for the preSxC9 or the HC groups. Overall, these analyses suggest that lGI and thickness capture independent characteristics of grey matter within our study cohort. To quantify the relative contributions of group, cortical thickness, age and sex to the variance of lGI, we performed an LSR analysis for regions in the preSxC9

Discussion

PreSxC9 feature structural brain deficits decades before expected symptom onset, with grey and white matter declines with age at a rate similar to controls,4 leading to the intriguing hypothesis that such deficits may represent neurodevelopmental differences. Because neurodevelopmental disorders such as dyslexia and autism feature regions of abnormally increased gyrification, we had hypothesised that preSxC9 would also show cortical regions of ‘hypergyrification’. In contrast to our hypothesis, we found that preSxC9 had no regions of increased gyrification, but instead regions of low lGI in the left subgenual anterior cingulate cortex, left precentral gyrus, right inferior parietal lobule and right superior occipital gyrus. Both preSxC9 and controls showed decreasing lGI across the adult age span studied, without any difference in slopes for the relationship between lGI and age. Low lGI values appeared in carriers as young as their 30s, consistent with previous findings that preSxC9 have grey matter deficits at this age.4 Interestingly, regions of low gyrification in preSxC9 only partially overlapped with regions of low grey matter thickness and volume, and within regions of low gyrification, cortical thickness was not a significant predictor of lGI variance. Moreover, gyrification and thickness were uncorrelated across the entire cortex. These findings support the notion that gyrification captures a feature of the cortex that is distinctive from grey matter thickness or volume and that gyrification may prove a useful marker for detecting differences in presymptomatic carriers.

PreSxC9 have low gyrification in regions atrophied during the symptomatic phase

As with sporadic bvFTD, patients with bvFTD due to the c9orf72 expansion show symmetric, prominent atrophy in the anterior insula, anterior cingulate and frontotemporal cortex.24–27 In contrast to sporadic bvFTD, c9orf72-bvFTD features parietal, occipital26 27 and thalamic atrophy.28 Similarly, patients with ALS due to the c9orf72 expansion show a more distributed atrophy pattern, with a greater degree of frontal and anterior cingulate atrophy29 and thalamic degeneration30 compared with sporadic ALS. PreSxC9 show grey matter deficits in regions that atrophy in c9orf72-bvFTD, including the anterior cingulate, medial frontal and dorsolateral prefrontal cortex, insula, precentral gyrus, precuneus, occipital cortex, striatum and medial thalamus.4 The regions with low gyrification in preSxC9 are congruent with regions of grey matter atrophy in c9orf72-bvFTD28 and grey matter volume deficits in preSxC9.4 PreSxC9 showed low lGI in the anterior cingulate cortex, which represents a key region of atrophy in bvFTD with or without c9orf72.28 31 The low lGI found in the primary motor cortex in presymptomatic carriers may presage future vulnerability to motor neuron disease that manifests during the symptomatic phase. Regions of low lGI also emerged in parieto-occipital cortex, consistent with grey matter atrophy and deficits in c9orf72-bvFTD and presymptomatic carriers.4 28

Low gyrification in preSxC9: neurodevelopmental versus neurodegenerative?

Whether regions of low gyrification in preSxC9 represent a neurodevelopmental difference or early atrophy remains an open question. We identified regions of low gyrification in carriers as young as their 30s, presumably decades before expected symptom onset. This finding is parallel to a previous study in which these same presymptomatic carriers showed grey matter volume and white matter deficits at a similar age.4 In the present study and the previous study, both lGI and grey and white matter declined with age in preSxC9 at rate similar to controls, suggesting that these deficits may be due to neurodevelopmental differences. Previous studies have revealed that children with dyslexia and autism show regions of abnormally high lGI. In dyslexia, regions with abnormally increased lGI correlate with neurite morphology, possibly associated with synaptic pruning deficits.15 In contrast to these developmental disorders in children, preSxC9 showed low lGI compared with controls. One possibility is that low gyrification represents a developmental deficit in cortical expansion in preSxC9, resulting in low lGI throughout the entire lifespan. A second possibility is that low lGI values could reflect that preSxC9 subjects ‘overprune’ gyri during adolescence and early adulthood to a degree beyond the typical decline in gyrification seen during adulthood. If due to developmental differences, these regions with low lGI may represent vulnerable regions that set the path for focal future neurodegeneration. A third consideration is that low lGI could represent early atrophy in preSxC9. PreSxC9 show gyrification declines with age at a rate similar to controls. If low lGI were to represent atrophy, however, we would expect to see accelerated lGI decline as seen in Alzheimer’s and Parkinson’s diseases,16 17 yet our cross-sectional data did not show an accelerated decline in lGI for older carriers. Future longitudinal studies, including those with children and adolescents, are needed to establish trajectories of lGI and other imaging metrics to determine the natural history of brain development.

Relationships between gyrification and other imaging measures

Our data suggest that the regions of low gyrification in preSxC9 were not attributable to cortical thickness deficits, consistent with other studies that have examined the relationship between lGI and other grey matter metrics. In a study of typically developing children and healthy adults, lGI correlated with grey matter volume but not with cortical thickness.7 In parallel, a study of adolescents with autism also showed that lGI and cortical thickness were uncorrelated, and that instead, lGI correlates with white matter architecture and connectivity.32 Previous studies suggest that gyrification has stronger associations with structural white matter connectivity rather than cortical thickness. In dyslexia, abnormally increased gyrification is correlated with neurite architecture changes as measured by neurite orientation dispersion and density imaging15; in autism spectrum disorder, increased gyrification is associated with altered white matter organisation.12 Although the mechanics of gyrification remain opaque, one theory suggests that cortical folding is driven to optimise white matter connections, as tension-mediated forces along axons bring highly connected regions closer to each other.6 In support of this theory, the immense increase in brain gyrification during the late fetal period coincides with an explosive development of cortico-cortical connections.6 15 33–36 Future studies will inform the relationships between white matter structural connectivity and gyrification in preSxC9 and other neurodevelopmental disorders.

Conclusions

PreSxC9 show regions of abnormally low gyrification in regions known to be targeted in c9orf72-FTD and c9orf72-ALS. If neurodevelopmental, deficits in gyrification and grey matter volume may confer vulnerability that predisposes selective brain regions to future neurodegeneration. Cortical gyrification represents a novel grey matter metric, and future longitudinal studies will clarify if low gyrification in preSxC9 represents a neurodevelopmental phenomenon.
  35 in total

1.  Multiparametric MRI study of ALS stratified for the C9orf72 genotype.

Authors:  Peter Bede; Arun L W Bokde; Susan Byrne; Marwa Elamin; Russell L McLaughlin; Kevin Kenna; Andrew J Fagan; Niall Pender; Daniel G Bradley; Orla Hardiman
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

2.  Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion.

Authors:  Suzee E Lee; Anna M Khazenzon; Andrew J Trujillo; Christine C Guo; Jennifer S Yokoyama; Sharon J Sha; Leonel T Takada; Anna M Karydas; Nikolas R Block; Giovanni Coppola; Mochtar Pribadi; Daniel H Geschwind; Rosa Rademakers; Jamie C Fong; Michael W Weiner; Adam L Boxer; Joel H Kramer; Howard J Rosen; Bruce L Miller; William W Seeley
Journal:  Brain       Date:  2014-10-01       Impact factor: 13.501

3.  Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family.

Authors:  Adam L Boxer; Ian R Mackenzie; Bradley F Boeve; Matthew Baker; William W Seeley; Richard Crook; Howard Feldman; Ging-Yuek R Hsiung; Nicola Rutherford; Victor Laluz; Jennifer Whitwell; Dean Foti; Eric McDade; Jennifer Molano; Anna Karydas; Aleksandra Wojtas; Jill Goldman; Jacob Mirsky; Pheth Sengdy; Stephen Dearmond; Bruce L Miller; Rosa Rademakers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-20       Impact factor: 10.154

4.  Increased gyrification, but comparable surface area in adolescents with autism spectrum disorders.

Authors:  Gregory L Wallace; Briana Robustelli; Nathan Dankner; Lauren Kenworthy; Jay N Giedd; Alex Martin
Journal:  Brain       Date:  2013-05-28       Impact factor: 13.501

5.  Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia.

Authors:  William W Seeley; Richard Crawford; Katya Rascovsky; Joel H Kramer; Michael Weiner; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Arch Neurol       Date:  2008-02

6.  Gyrification differences in children and adolescents with velocardiofacial syndrome and attention-deficit/hyperactivity disorder: a pilot study.

Authors:  Sabine E Mous; Canan Karatekin; Chiu-Yen Kao; Irving I Gottesman; Danielle Posthuma; Tonya White
Journal:  Psychiatry Res       Date:  2013-12-13       Impact factor: 3.222

7.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

8.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Bradley F Boeve; Matthew L Senjem; Jeffrey L Gunter; Mariely DeJesus-Hernandez; Nicola J Rutherford; Matthew Baker; David S Knopman; Zbigniew K Wszolek; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

9.  Cortical thickness, surface area, and folding alterations in male youths with conduct disorder and varying levels of callous-unemotional traits.

Authors:  Graeme Fairchild; Nicola Toschi; Cindy C Hagan; Ian M Goodyer; Andrew J Calder; Luca Passamonti
Journal:  Neuroimage Clin       Date:  2015-04-30       Impact factor: 4.881

10.  Lifespan Gyrification Trajectories of Human Brain in Healthy Individuals and Patients with Major Psychiatric Disorders.

Authors:  Bo Cao; Benson Mwangi; Ives Cavalcante Passos; Mon-Ju Wu; Zafer Keser; Giovana B Zunta-Soares; Dianping Xu; Khader M Hasan; Jair C Soares
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

View more
  7 in total

Review 1.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

2.  Novel Gyrification Networks Reveal Links with Psychiatric Risk Factors in Early Illness.

Authors:  Rachele Sanfelici; Anne Ruef; Linda A Antonucci; Nora Penzel; Aristeidis Sotiras; Mark Sen Dong; Maria Urquijo-Castro; Julian Wenzel; Lana Kambeitz-Ilankovic; Meike D Hettwer; Stephan Ruhrmann; Katharine Chisholm; Anita Riecher-Rössler; Peter Falkai; Christos Pantelis; Raimo K R Salokangas; Rebekka Lencer; Alessandro Bertolino; Joseph Kambeitz; Eva Meisenzahl; Stefan Borgwardt; Paolo Brambilla; Stephen J Wood; Rachel Upthegrove; Frauke Schultze-Lutter; Nikolaos Koutsouleris; Dominic B Dwyer
Journal:  Cereb Cortex       Date:  2022-04-05       Impact factor: 4.861

3.  Temporal order of clinical and biomarker changes in familial frontotemporal dementia.

Authors:  Adam M Staffaroni; Melanie Quintana; Barbara Wendelberger; Hilary W Heuer; Lucy L Russell; Yann Cobigo; Amy Wolf; Sheng-Yang Matt Goh; Leonard Petrucelli; Tania F Gendron; Carolin Heller; Annie L Clark; Jack Carson Taylor; Amy Wise; Elise Ong; Leah Forsberg; Danielle Brushaber; Julio C Rojas; Lawren VandeVrede; Peter Ljubenkov; Joel Kramer; Kaitlin B Casaletto; Brian Appleby; Yvette Bordelon; Hugo Botha; Bradford C Dickerson; Kimiko Domoto-Reilly; Julie A Fields; Tatiana Foroud; Ralitza Gavrilova; Daniel Geschwind; Nupur Ghoshal; Jill Goldman; Jonathon Graff-Radford; Neill Graff-Radford; Murray Grossman; Matthew G H Hall; Ging-Yuek Hsiung; Edward D Huey; David Irwin; David T Jones; Kejal Kantarci; Daniel Kaufer; David Knopman; Walter Kremers; Argentina Lario Lago; Maria I Lapid; Irene Litvan; Diane Lucente; Ian R Mackenzie; Mario F Mendez; Carly Mester; Bruce L Miller; Chiadi U Onyike; Rosa Rademakers; Vijay K Ramanan; Eliana Marisa Ramos; Meghana Rao; Katya Rascovsky; Katherine P Rankin; Erik D Roberson; Rodolfo Savica; M Carmela Tartaglia; Sandra Weintraub; Bonnie Wong; David M Cash; Arabella Bouzigues; Imogen J Swift; Georgia Peakman; Martina Bocchetta; Emily G Todd; Rhian S Convery; James B Rowe; Barbara Borroni; Daniela Galimberti; Pietro Tiraboschi; Mario Masellis; Elizabeth Finger; John C van Swieten; Harro Seelaar; Lize C Jiskoot; Sandro Sorbi; Chris R Butler; Caroline Graff; Alexander Gerhard; Tobias Langheinrich; Robert Laforce; Raquel Sanchez-Valle; Alexandre de Mendonça; Fermin Moreno; Matthis Synofzik; Rik Vandenberghe; Simon Ducharme; Isabelle Le Ber; Johannes Levin; Adrian Danek; Markus Otto; Florence Pasquier; Isabel Santana; John Kornak; Bradley F Boeve; Howard J Rosen; Jonathan D Rohrer; Adam L Boxer
Journal:  Nat Med       Date:  2022-09-22       Impact factor: 87.241

4.  Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond.

Authors:  Dario Saracino; Isabelle Le Ber
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.

Authors:  Joke De Vocht; Jeroen Blommaert; Martijn Devrome; Ahmed Radwan; Donatienne Van Weehaeghe; Maxim De Schaepdryver; Jenny Ceccarini; Ahmadreza Rezaei; Georg Schramm; June van Aalst; Adriano Chiò; Marco Pagani; Daphne Stam; Hilde Van Esch; Nikita Lamaire; Marianne Verhaegen; Nathalie Mertens; Koen Poesen; Leonard H van den Berg; Michael A van Es; Rik Vandenberghe; Mathieu Vandenbulcke; Jan Van den Stock; Michel Koole; Patrick Dupont; Koen Van Laere; Philip Van Damme
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

6.  White matter volume loss drives cortical reshaping after thalamic infarcts.

Authors:  Julian Conrad; Maximilian Habs; Ria M Ruehl; Rainer Bögle; Matthias Ertl; Valerie Kirsch; Ozan E Eren; Sandra Becker-Bense; Thomas Stephan; Frank A Wollenweber; Marco Duering; Peter Zu Eulenburg; Marianne Dieterich
Journal:  Neuroimage Clin       Date:  2022-02-04       Impact factor: 4.881

7.  Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions.

Authors:  Rachel Smallwood Shoukry; Rebecca Waugh; Dan Bartlett; Denitza Raitcheva; Mary Kay Floeter
Journal:  Neuroimage Clin       Date:  2020-07-20       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.